Veradigm Inc. (NASDAQ:MDRX - Get Free Report) shares saw strong trading volume on Thursday . 380,509 shares were traded during trading, an increase of 63% from the previous session's volume of 233,154 shares.The stock last traded at $8.35 and had previously closed at $8.52.
Wall Street Analyst Weigh In
Separately, StockNews.com began coverage on Veradigm in a research report on Monday. They set a "hold" rating for the company.
Get Our Latest Stock Report on Veradigm
Veradigm Stock Performance
The business has a 50 day moving average of $9.90 and a two-hundred day moving average of $9.71.
Veradigm Company Profile
(
Get Free Report)
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Veradigm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.
While Veradigm currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
